These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6783633)

  • 1. Preparation of biologically active fluorescent heparin composed of fluorescein-labeled species and its behavior to antithrombin III.
    Uchiyama H; Nagasawa K
    J Biochem; 1981 Jan; 89(1):185-92. PubMed ID: 6783633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and properties of biologically active fluorescent heparins.
    Nagasawa K; Uchiyama H
    Biochim Biophys Acta; 1978 Dec; 544(2):430-40. PubMed ID: 719009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of heparin into fractions with different anticoagulant activity by hydrophobic interaction chromatography.
    Ogamo A; Uchiyama H; Nagasawa K
    Biochim Biophys Acta; 1980 Dec; 626(2):477-85. PubMed ID: 7213665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between heparin and antithrombin III: a comparison of two different heparin-dye conjugates.
    Jones GR; Hashim R; Power DM
    Biochim Biophys Acta; 1987 Jul; 925(1):57-62. PubMed ID: 3109497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of affinity for antithrombin III by supplemental sulfation of heparin species with low affinity for the protein.
    Ogamo A; Metori A; Uchiyama H; Nagasawa K
    J Biochem; 1990 Oct; 108(4):588-92. PubMed ID: 2292586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of heparin fractions and other polysulfated polysaccharides to plasma fibronectin: effects of molecular size and degree of sulfation of polysaccharides.
    Ogamo A; Nagai A; Nagasawa K
    Biochim Biophys Acta; 1985 Jul; 841(1):30-41. PubMed ID: 2861857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of heparin on Sepharose CL-4B in the presence of high concentrations of ammonium sulphate.
    Uchiyama H; Fujimoto N; Sakurai K; Nagasawa K
    J Chromatogr; 1984 Mar; 287(1):55-66. PubMed ID: 6725457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of chemical 6-O-sulfation of the aminodeoxyhexose residues in whale heparin with high affinity for antithrombin III to its anticoagulant properties.
    Uchiyama H; Metori A; Ogamo A; Nagasawa K
    J Biochem; 1990 Mar; 107(3):377-80. PubMed ID: 2341372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK; Nader HB; Dietrich CP
    Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and properties of fluorescent glycosaminoglycuronans labeled with 5-aminofluorescein.
    Ogamo A; Matsuzaki K; Uchiyama H; Nagasawa K
    Carbohydr Res; 1982 Jul; 105(1):69-85. PubMed ID: 7116357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-inhibitory activity of whale heparin oligosaccharides.
    Ototani N; Kodama C; Kikuchi M; Yosizawa Z
    J Biochem; 1984 Dec; 96(6):1695-703. PubMed ID: 6530392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the antithrombin-binding site in heparin.
    Lindahl U; Bäckström G; Höök M; Thunberg L; Fransson LA; Linker A
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3198-202. PubMed ID: 226960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant activity of heparin octasaccharide.
    Ototani N; Yosizawa Z
    J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies on the structures of highly active and relatively inactive forms of whale heparin.
    Ototani N; Kikuchi M; Yosizawa Z
    J Biochem; 1981 Jul; 90(1):241-6. PubMed ID: 7287679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
    Ototani N; Kikuchi M; Yosizawa Z
    Biochem J; 1982 Jul; 205(1):23-30. PubMed ID: 7126178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.
    Andrade-Gordon P; Strickland S
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1865-9. PubMed ID: 2106684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method to determine the affinity of heparin to thrombin and antithrombin III on equilibrium gel permeation chromatography.
    Oshima G; Uchiyama H; Nagasawa K
    J Biochem; 1984 Oct; 96(4):1033-9. PubMed ID: 6520110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.